425394-89-4

Basic information

• Product Name: 5-Pyrimidinol,4,6-dichloro-(9CI)
• Synonyms: 5-Pyrimidinol,4,6-dichloro-(9CI);4,6-dichloropyriMidin-5-ol;4,6-Dichloro-5-hydroxypyrimidine;4,6-Dichloro-5-pyrimidinol
• CAS NO: 425394-89-4
• Molecular Formula: C₄H₂Cl₂N₂O
• Molecular Weight: 164.97748
• Product Categories: HALIDE
• Mol File: 425394-89-4.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 242℃
• Flash Point: 100℃
• Appearance: /
• Density: 1.679
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 3.66±0.20(Predicted)
• CAS DataBase Reference: 5-Pyrimidinol,4,6-dichloro-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Pyrimidinol,4,6-dichloro-(9CI)(425394-89-4)
• EPA Substance Registry System: 5-Pyrimidinol,4,6-dichloro-(9CI)(425394-89-4)

Safety Data

• Hazardous Substances Data: 425394-89-4(Hazardous Substances Data)

Usage

General Description

5-Pyrimidinol,4,6-dichloro-(9CI) is a chemical compound with the molecular formula C4H2Cl2N2O. It is a pyrimidine derivative with two chlorine atoms attached to carbon atoms 4 and 6 of the pyrimidine ring. 5-Pyrimidinol,4,6-dichloro-(9CI) is commonly used in the pharmaceutical and agricultural industries for its potential biological activities. It is also known for its ability to inhibit the activity of certain enzymes and proteins, making it a promising candidate for drug development and agricultural applications. Additionally, 5-Pyrimidinol,4,6-dichloro-(9CI) is under research for its potential use as a fungicide and herbicide due to its ability to inhibit the growth of unwanted microorganisms and plants. However, further research is needed to fully understand its biological and agricultural potential.

Upstream product

• 5018-38-2 4,6-dichloro-5-methoxypyrimidine 

Downstream Products

• 1206181-50-1 5-(benzyloxy)-4,6-dichloropyrimidine 

Relevant articles and documents

Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors

BTK is a tyrosine kinase playing an important role in B cell and myeloid cell functions through B cell receptor (BCR) signaling and Fc receptor (FcR) signaling. Selective inhibition of BTK has the potential to provide therapeutical benefits to patients su

ANTIBACTERIAL COMPOUNDS

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting the growth of gram-negative bacteria. Furthermore, the subject compounds and compositions are useful for the treatment of bacterial infection, such as urinary tract infection and the like.

ANTIBACTERIAL COMPOUNDS

Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for inhibiting the growth of gram-negative bacteria. Furthermore, the subject compounds and compositions are useful for the treatment of bacterial infection, such as urinary tract infection and the like.